Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 12.39
-1.04 %
$ 1.13 B
Market Cap
-9.68
P/E
MYGN - STOCK-BASED COMPENSATION
Stock-based Compensation MYGN - Myriad Genetics, Inc.
40.7 M
LAST VALUE
5.89%
2 YEAR CAGR
3.97%
5 YEAR CAGR
4.16%
10 YEAR CAGR